Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008839 |
---|---|
Receipt number | R000010382 |
Scientific Title | Randomized phase II study of eribulin versus nab-paclitaxel in patients with relapsed HER2-negative breast cancer previously treated with anthracycline and peri-operative taxane |
Date of disclosure of the study information | 2012/10/01 |
Last modified on | 2014/04/11 14:56:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/09/03 15:20:42 | ||
2 | Update | 2013/04/18 09:17:42 | Email1 |
|
3 | Update | 2013/12/27 17:13:27 | Recruitment status |
|
4 | Update | 2014/04/11 14:56:37 | Recruitment status |